Health Rounds: J&J drug helps delay multiple myeloma in high-risk patients
The Johnson & Johnson drug Darzalex showed promise in helping keep a precancerous condition from progressing to the blood ...
Cancer Therapy Advisor4d
Paclitaxel and Nab-Paclitaxel Deemed Comparable for High-Risk Early Breast Cancer
Paclitaxel-based and nab-paclitaxel-based chemotherapy produced similar 5-year outcomes in patients with high-risk, HR+, HER2- early breast cancer.
The Register-Herald5d
Rockefeller Neuroscience Institute expands access to groundbreaking Alzheimer’s treatment
The WVU Rockefeller Neuroscience Institute (RNI) is providing patients greater statewide and regional access to a ...